News &amp; Updates

Smoking cessation appears to be correlated with lower levels of oxidized high-density lipoprotein (oxHDL) and higher levels of HDL-cholesterol (c), a recent study has found.

Quitting smoking may lead to a better vascular health

Progestin shows therapeutic potential in PR-positive endometrial cancer

Progestin therapy appears to yield high response rates in advanced stage and recurrent endometrial cancer that is positive for progesterone receptor (PR) expression, while having low toxicity, according to a study.

Progestin shows therapeutic potential in PR-positive endometrial cancer

08 Dec 2022

High-intensity focused ultrasound safe, effective for cirrhotic secondary hypersplenism

High-intensity focused ultrasound (HIFU) appears to be a safe, effective, and minimally invasive treatment option for patients with cirrhotic secondary hypersplenism, a recent study has found.

High-intensity focused ultrasound safe, effective for cirrhotic secondary hypersplenism

Veverimer does not delay CKD progression

Treatment with once-daily veverimer did not delay chronic kidney disease (CKD) progression, according to the results of the phase III VALOR-CKD trial.

Veverimer does not delay CKD progression

Minimally invasive surgery safer but less effective than open surgery in children with DRE

In the treatment of children with drug-resistant epilepsy (DRE), minimally invasive magnetic resonance-guided laser interstitial thermal therapy is associated with lower rate of seizure freedom at 1 year but has the advantage of lower complication rates and shorter hospitalization as compared with open surgery, as shown in a study.

Minimally invasive surgery safer but less effective than open surgery in children with DRE

A new consensus recommends care, management of obesity in Asia

A new consensus paper on preliminary recommendations for the management and care of obesity in adults and children was released in October.

A new consensus recommends care, management of obesity in Asia

Evusheld monoclonal antibody combination now available in Malaysia’s private market for prevention of COVID-19 in high-risk individuals

AstraZeneca’s Evusheld (tixagevimab and cilgavimab, MAL 22056042ACR2), a monoclonal antibody combination, has been launched today in Malaysia’s private hospitals for the prevention of COVID-19 in high-risk individuals.

Evusheld monoclonal antibody combination now available in Malaysia’s private market for prevention of COVID-19 in high-risk individuals

Mindfulness-based classes help fight depression during pregnancy, postpartum period

A group-based mindfulness intervention during pregnancy appears to favourably affect the well-being of women, with the benefit persisting through the postpartum period, as shown in a recent study.

Mindfulness-based classes help fight depression during pregnancy, postpartum period

Degarelix tied to BMD decrease in prostate cancer

Treatment with degarelix results in a substantial reduction in bone mineral density (BMD) and an increase in bone turnover markers, reports a study.

Degarelix tied to BMD decrease in prostate cancer

PCSK9 inhibitors safe, effective in Asian patients, but expensive to use

PCSK9 inhibitors alirocumab and evolocumab are not only safe and well tolerated but also efficacious in Asian patients, results of a real-world study in Singapore have shown. However, about a third of patients stopped using these medications due to their high costs.

PCSK9 inhibitors safe, effective in Asian patients, but expensive to use